Stocklytics Platform
Asset logo for symbol SHPH
Shuttle Pharmaceuticals Holdings
SHPH31
$0.68arrow_drop_up7.17%$0.04
Penny Stock
Asset logo for symbol SHPH
SHPH31

$0.68

arrow_drop_up7.17%

Performance History

Chart placeholder
Key Stats
Open$0.64
Prev. Close$0.64
EPS-4.25
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.34M
PE Ratio-
LOWHIGH
Day Range0.64
0.68
52 Week Range0.52
5.35
Ratios
Revenue-
EBITDA Margin %-
EPS-4.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Shuttle Pharmaceuticals Holdings (SHPH)

Shuttle Pharmaceuticals Holdings Inc (SHPH) is a pharmaceutical company that specializes in the research, development, and commercialization of innovative drugs. With a strong focus on improving patient outcomes and addressing unmet medical needs, SHPH has established itself as a leader in the industry. The company's stock price history reflects its consistent growth and investor confidence. Over the past several years, SHPH's stock price has steadily increased, demonstrating the market's recognition of its value. This upward trajectory is a testament to SHPH's strong business fundamentals and promising pipeline of drug candidates.
As of the latest quote, SHPH's stock is trading at a favorable price, making it an attractive investment opportunity. The company's impressive portfolio and commitment to excellence have garnered the attention of industry experts, resulting in positive stock news coverage. Analysts have praised SHPH for its strategic acquisitions, partnerships, and successful clinical trials. These developments have significantly contributed to SHPH's market capitalization, which currently stands at a substantial figure.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Dr. Anatoly Dritschilo M.D.
Headquarters
Rockville
Employees
7
Exchange
NASDAQ
add Shuttle Pharmaceuticals Holdings  to watchlist

Keep an eye on Shuttle Pharmaceuticals Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Shuttle Pharmaceuticals Holdings 's (SHPH) price per share?

The current price per share for Shuttle Pharmaceuticals Holdings (SHPH) is $0.69. The stock has seen a price change of $0.05 recently, indicating a 7.17% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Shuttle Pharmaceuticals Holdings (SHPH)?

For Shuttle Pharmaceuticals Holdings (SHPH), the 52-week high is $5.35, which is 680.17% from the current price. The 52-week low is $0.52, the current price is 31.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Shuttle Pharmaceuticals Holdings (SHPH) a growth stock?

Shuttle Pharmaceuticals Holdings (SHPH) has shown an average price growth of -4.97% over the past three years. It has received a score of 21 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Shuttle Pharmaceuticals Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Shuttle Pharmaceuticals Holdings (SHPH) stock price performance year to date (YTD)?

As of the latest data, Shuttle Pharmaceuticals Holdings (SHPH) has a year-to-date price change of -83%. Over the past month, the stock has experienced a price change of -21.24%. Over the last three months, the change has been -49.93%. Over the past six months, the figure is -77.63%.
help

Is Shuttle Pharmaceuticals Holdings (SHPH) a profitable company?

Shuttle Pharmaceuticals Holdings (SHPH) has a net income of -$6.59M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$5.89M. Furthermore, the EBITDA is -$5.74M.
help

What is the market capitalization of Shuttle Pharmaceuticals Holdings (SHPH)?

Shuttle Pharmaceuticals Holdings (SHPH) has a market capitalization of $2.35M. The average daily trading volume is 0.69, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level